CIK 0001520262 · Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981007018
- Phone
- 00-353-1-772-8000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,070,874
- in 5 filings, $1.1M under 10b5-1 plans
Net −$1,070,874. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-23 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Option exercise | +7,689 | 92,986 | ||
| 2026-02-23 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Shares withheld for taxes | −3,414 | $32.19 | $110K | 89,572 |
| 2026-02-23 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Option exercise · Restricted Stock Unit Award | −7,689 | 7,690 | ||
| 2026-02-23 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Option exercise | +7,689 | 239,291 | ||
| 2026-02-23 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Shares withheld for taxes | −3,414 | $32.19 | $110K | 235,877 |
| 2026-02-23 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Option exercise · Restricted Stock Unit Award | −7,689 | 7,690 | ||
| 2026-02-19 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Option exercise | +2,991 | 12,036 | ||
| 2026-02-19 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Shares withheld for taxes | −979 | $32.00 | $31K | 11,057 |
| 2026-02-19 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Option exercise · Restricted Stock Unit Award | −2,991 | 8,974 | ||
| 2026-02-19 | Nichols Christian Todd SVP, Chief Commercial Officer | Option exercise | +6,045 | 111,477 | ||
| 2026-02-19 | Nichols Christian Todd SVP, Chief Commercial Officer | Shares withheld for taxes | −2,277 | $32.00 | $73K | 109,200 |
| 2026-02-19 | Nichols Christian Todd SVP, Chief Commercial Officer | Option exercise · Restricted Stock Unit Award | −6,045 | 18,137 | ||
| 2026-02-19 | Jackson Blair Curtis EVP, Chief Operating Officer | Option exercise | +9,300 | 235,953 | ||
| 2026-02-19 | Jackson Blair Curtis EVP, Chief Operating Officer | Shares withheld for taxes | −4,130 | $32.00 | $132K | 231,823 |
| 2026-02-19 | Jackson Blair Curtis EVP, Chief Operating Officer | Option exercise · Restricted Stock Unit Award | −9,300 | 27,903 | ||
| 2026-02-19 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Option exercise | +7,673 | 88,704 | ||
| 2026-02-19 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Shares withheld for taxes | −3,407 | $32.00 | $109K | 85,297 |
| 2026-02-19 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Option exercise · Restricted Stock Unit Award | −7,673 | 23,019 | ||
| 2026-02-19 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Option exercise | +7,673 | 235,009 | ||
| 2026-02-19 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Shares withheld for taxes | −3,407 | $32.00 | $109K | 231,602 |
Page 8 of 41 · 804 trades